Dluh/Vlastní kapitál společnosti Amgen
Jaká je hodnota metriky Dluh/Vlastní kapitál společnosti Amgen?
Hodnota metriky Dluh/Vlastní kapitál společnosti Amgen, Inc. je 2.24
Jaká je definice metriky Dluh/Vlastní kapitál?
Poměr dluhu k vlastnímu kapitálu (debt to equity ratio) udává podíl vlastního kapitálu a cizích zdrojů na financování majetku společnosti.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dluh/Vlastní kapitál společností v sektoru Health Care sektor na XETRA ve srovnání se společností Amgen
Čemu se věnuje společnost Amgen?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Firmy s metrikou dluh/vlastní kapitál podobnou společnosti Amgen
- Hodnota metriky Dluh/Vlastní kapitál společnosti Bunge je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Eveready Industries India je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Ashnoor Textile Mills je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Rashtriya Chemicals and Fertilizers je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Keller Plc je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti China Molybdenum Co je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Amgen je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Glencore Plc je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Glencore Plc je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Inox Wind je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Viasat je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti Dividend 15 Split je 2.24
- Hodnota metriky Dluh/Vlastní kapitál společnosti PRGX Global Inc je 2.24